ATLANTA, Sept. 22 /PRNewswire/ -- Elekta, the international medical technology group, and global leader in neurosurgery and radiation oncology solutions, today announced the formation of Elekta Capital(TM). Elekta Capital will work to provide financing to Elekta’s North American customers together with De Lage Landen, a Netherlands-based international provider of high- quality asset financing products with a strong presence in healthcare.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )
Elekta Capital(TM) will assist customers in arranging competitive financing for Elekta’s leading edge treatment solutions, allowing customers to work with experts who understand the specific needs of the healthcare marketplace as well as the advantages offered by Elekta.
“Elekta has always offered a full range of services to support the entire lifecycle of our treatment solutions,” said Anthony De Carolis, President and CEO of Elekta Inc. “This new initiative will simplify the acquisition of Elekta’s solutions and improve the competitiveness offered by our proven business model.”
“De Lage Landen has a fiscally strong, international presence with a thorough understanding of the requirements of medical facilities,” De Carolis added. “They are known for their outstanding customer support, which complements our philosophy and approach.”
About De Lage Landen:
De Lage Landen is a Netherlands-based international provider of high- quality asset financing products. With a presence in more than 20 countries across the globe, the company focuses on the following industries: Food & Agriculture, Healthcare, Office Equipment, Telecommunications, Information Technology, Materials Handling & Construction Equipment and Financial Institutions. In its domestic market, the company offers Equipment Leasing, Consumer Finance, Car & Commercial Vehicle Leasing, ICT Leasing and Trade Finance through local Rabobanks and direct to market. De Lage Landen is a wholly owned subsidiary of the Dutch Rabobank Group that is AAA-rated by Moody’s and Standard & Poors. In 2003 De Lage Landen grew its profits to $129.7 million (EUR 114.8 million) and its balance sheet total to $17.8 billion (EUR 14.1 billion). For further information, please visit http://www.delagelanden.com/ .
Photo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGOPRN Photo Desk, photodesk@prnewswire.comElekta Instruments, Inc.
CONTACT: Michelle Lee, PR and Advertising Manager, +1-770-670-2447, ormichelle.lee@elekta.com , or Investors, United States, Lars Jonsteg, VPInvestor Relations North America, +1-770-670-2419, orlars.jonsteg@elekta.com , or International, Peter Ejemyr, Group VP CorporateCommunications, +46-8-587-254-00, or peter.ejemyr@elekta.com , all of Elekta